Skip to main content

Table 3 Characteristics of HIV infection of HIV/AIDS patients treated with ART in Guangxi between 2003 and 2019

From: Predictive factors of viral load high-risk events for virological failure in HIV/AIDS patients receiving long-term antiviral therapy

Variables

Total (%) (n = 1860)

HR (%)

(n = 218)

non-HR (%) (n = 1642)

χ2/Z

P

Transmission route

   

10.158

0.038

Heterosexual

1438 (77.31)

176 (80.73)

1262 (76.86)

  

Intravenous drug use or blood exchange

53 (2.85)

11 (5.05)

42 (2.56)

  

Homosexual

308 (16.56)

24 (11.01)

284 (17.30)

  

Vertical

7 (0.38)

0 (0.00)

7 (0.43)

  

Unknown

54 (2.90)

7 (3.21)

47 (2.86)

  

Mtb infection in the recent year

   

5.007

0.082

Yes

164 (8.82)

28 (12.84)

136 (8.28)

  

No

1680 (90.32)

188 (86.24)

1492 (90.86)

  

Unknown

16 (0.86)

2 (0.92)

14 (0.85)

  

OIs in the recent 3 months

   

15.511

<  0.001

Yes

587 (31.56)

94 (43.12)

493 (30.02)

  

No

1244 (66.88)

122 (55.96)

1122 (68.33)

  

Unknown

29 (1.56)

2 (0.92)

27 (1.64)

  

AIDS-related symptoms

   

0.532

0.466

Yes

252 (13.55)

33 (15.14)

219 (13.34)

  

No

1608 (86.45)

185 (84.86)

1423 (86.66)

  

WHO clinical stage

   

10.499

0.015

I

1068 (57.42)

103 (47.25)

965 (58.77)

  

II

202 (10.86)

29 (13.30)

173 (10.54)

  

III

218 (11.72)

31 (14.22)

187 (11.39)

  

IV

372 (20.00)

55 (25.23)

317 (19.31)

  

CD4+ T-cell count (cells/ml)

211 (58, 329)

156 (33, 294)

220 (62.5, 333)

−3.604

< 0.001

Viral Load (Log10 copies/ml) (Median, IQR)

4.89 (4.37, 5.38)

5.08 (4.38, 5.60)

4.85 (4.31, 5.35)

−3.467

0.001

Cotrimoxazole use before baseline

   

1.499

0.221

Yes

573 (30.81)

75 (34.40)

498 (30.33)

  

No

1287 (69.19)

143 (65.60)

1144 (69.67)

  

Total

1860 (100.00)

218 (11.72)

1642 (88.28)